{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:25:06Z","timestamp":1789655106250,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Loyola University Medical Center"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jpsychires.2019.10.004","type":"journal-article","created":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T08:29:44Z","timestamp":1570436984000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Altered plasma levels of arginine metabolites in depression"],"prefix":"10.1016","volume":"120","author":[{"given":"Arisoy","family":"Ozden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halaris","family":"Angelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aricioglu","family":"Feyza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wild","family":"Elizabeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piletz","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2019.10.004_bib1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00726-009-0396-7","article-title":"Polyamines: fundamental characters in chemistry and biology","volume":"38","author":"Agostinelli","year":"2010","journal-title":"Amino Acids"},{"key":"10.1016\/j.jpsychires.2019.10.004_bib2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1196\/annals.1304.014","article-title":"Is agmatine an endogenous anxiolytic\/antidepressant agent?","volume":"1009","author":"Aricioglu","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib3","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s11064-010-0240-1","article-title":"Clomipramine treatment and repeated restraint stress alter parameters of oxidative stress in brain regions of male rats","volume":"35","author":"Balk Rde","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/PSY.0000000000000042","article-title":"Asymmetric dimethylarginine responses during interferon-alpha-induced depression in patients with chronic hepatitis C infection","volume":"76","author":"Baranyi","year":"2014","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143397","article-title":"Nitric oxide-related biological pathways in patients with major depression","volume":"10","author":"Baranyi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2019.10.004_bib6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00726-009-0402-0","article-title":"Agmatine prevents the Ca(2+)-dependent induction of permeability transition in rat brain mitochondria","volume":"38","author":"Battaglia","year":"2010","journal-title":"Amino Acids"},{"key":"10.1016\/j.jpsychires.2019.10.004_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2011.07.012","article-title":"Agmatinase, an inactivator of the putative endogenous antidepressant agmatine, is strongly upregulated in hippocampal interneurons of subjects with mood disorders","volume":"62","author":"Bernstein","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpsychires.2019.10.004_bib8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pnpbp.2012.01.009","article-title":"Agmatine, an endogenous ligand of imidazoline receptor protects against memory impairment and biochemical alterations in streptozotocin-induced diabetic rats","volume":"37","author":"Bhutada","year":"2012","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.10.004_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/624395","article-title":"Relationship of asymmetrical dimethylarginine, nitric oxide, and sustained attention during attack in patients with major depressive disorder","author":"Canpolat","year":"2014","journal-title":"Sci. World J."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163634","article-title":"Agmatine reduces lipopolysaccharide-mediated oxidant response via activating PI3K\/Akt pathway and up-regulating Nrf2 and HO-1 expression in macrophages","volume":"11","author":"Chai","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2019.10.004_bib11","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/ijnp\/pyy058","article-title":"Evidence of reduced agmatine concentrations in the cerebral cortex of suicides","volume":"21","author":"Chen","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1471-4159.2010.07085.x","article-title":"Agmatine effects on mitochondrial membrane potential and NF-kappaB activation protect against rotenone-induced cell damage in human neuronal-like SH-SY5Y cells","volume":"116","author":"Condello","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0278-5846(99)00100-1","article-title":"Increased serum arginase activity in depressed patients","volume":"24","author":"Elgun","year":"2000","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.10.004_bib14","doi-asserted-by":"crossref","first-page":"18994","DOI":"10.1073\/pnas.0803464105","article-title":"Endogenous polyamines regulate cortical neuronal excitability by blocking voltage-gated Na+ channels","volume":"105","author":"Fleidervish","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib15","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1007\/s12035-014-8827-1","article-title":"Agmatine induces Nrf2 and protects against corticosterone effects in hippocampal neuronal cell line","volume":"51","author":"Freitas","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib16","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.euroneuro.2016.10.013","article-title":"Agmatine, a potential novel therapeutic strategy for depression","volume":"26","author":"Freitas","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3109\/00207454.2012.693998","article-title":"Chronic immobilization in the malpar1 knockout mice increases oxidative stress in the hippocampus","volume":"122","author":"Garcia-Fernandez","year":"2012","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2016.07.004","article-title":"Agmatine ameliorates lipopolysaccharide induced depressive-like behaviour in mice by targeting the underlying inflammatory and oxido-nitrosative mediators","volume":"149","author":"Gawali","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.brainres.2017.03.004","article-title":"Agmatine attenuates chronic unpredictable mild stress-induced anxiety, depression-like behaviours and cognitive impairment by modulating nitrergic signalling pathway","volume":"1663","author":"Gawali","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0006-2952(00)00517-7","article-title":"The polyamine stress response: tissue-, endocrine-, and developmental-dependent regulation","volume":"61","author":"Gilad","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00726-011-0991-2","article-title":"Mitochondrial oxidative stress induced by Ca2+ and monoamines: different behaviour of liver and brain mitochondria in undergoing permeability transition","volume":"42","author":"Grancara","year":"2012","journal-title":"Amino Acids"},{"issue":"1","key":"10.1016\/j.jpsychires.2019.10.004_bib22","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1038\/s41598-019-40353-8","article-title":"Circadian and wake-dependent changes in human plasma polar metabolites during prolonged wakefullness: a preliminary analysis","volume":"14;9","author":"Grant","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib23","doi-asserted-by":"crossref","first-page":"980","DOI":"10.2174\/18715273113129990095","article-title":"Suicide and the polyamine system","volume":"12","author":"Gross","year":"2013","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.jpsychires.2019.10.004_bib24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1749-6632.1999.tb09392.x","article-title":"Plasma agmatine and platelet imidazoline receptors in depression","volume":"881","author":"Halaris","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib25","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2165\/00023210-200721110-00002","article-title":"Agmatine : metabolic pathway and spectrum of activity in brain","volume":"21","author":"Halaris","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychires.2019.10.004_bib26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0166-4328(02)00084-0","article-title":"Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats","volume":"134","author":"Heiberg","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/jnnp-2011-301779","article-title":"Depression: an inflammatory illness?","volume":"83","author":"Krishnadas","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.10.004_bib28","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1042\/BCJ20170007","article-title":"Agmatine: multifunctional arginine metabolite and magic bullet in clinical neuroscience?","volume":"474","author":"Laube","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jad.2013.06.033","article-title":"Serum methylarginines and incident depression in a cohort of older adults","volume":"151","author":"McEvoy","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.116","article-title":"Involvement of the agmatinergic system in the depressive-like phenotype of the Crtc1 knockout mouse model of depression","volume":"6","author":"Meylan","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.10.004_bib31","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neuint.2011.05.002","article-title":"Stress, glucocorticoids and glutamate release: effects of antidepressant drugs","volume":"59","author":"Musazzi","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib32","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbr.2013.12.038","article-title":"Depressive-like behavior induced by tumor necrosis factor-alpha is abolished by agmatine administration","volume":"261","author":"Neis","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pbb.2016.10.004","article-title":"Acute agmatine administration, similar to ketamine, reverses depressive-like behavior induced by chronic unpredictable stress in mice","volume":"150\u2013151","author":"Neis","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib34","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.pnpbp.2017.08.017","article-title":"Antidepressant and pro-neurogenic effects of agmatine in a mouse model of stress induced by chronic exposure to corticosterone","volume":"81","author":"Olescowicz","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2019.10.004_bib35","first-page":"274","article-title":"Nitric oxide branch of arginine metabolism in depression: effect of venlafaxine","volume":"2","author":"Piletz","year":"2009","journal-title":"Int. J. Health Sci."},{"issue":"17\u201318","key":"10.1016\/j.jpsychires.2019.10.004_bib36","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.drudis.2013.05.017","article-title":"Agmatine: clinical applications after 100 years in translation","volume":"18","author":"Piletz","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jpsychires.2019.10.004_bib37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fnut.2019.00024","article-title":"Dietary and gut microbiota polyamines in obesity- and age-related diseases","volume":"6","author":"Ramos-Molina","year":"2019","journal-title":"Front. Nutr."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/PSY.0000000000000077","article-title":"Arginine and asymmetric dimethylarginine in pregnant women with major depression","volume":"76","author":"Raw","year":"2014","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib39","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1749-6632.1999.tb09389.x","article-title":"Anti-proliferative and anti-inflammatory actions of imidazoline agents. Are imidazoline receptors involved?","volume":"881","author":"Regunathan","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib40","series-title":"Synopsis of Psychiatry and Behavioral Sciences\/Clinical Psychiatry","author":"Sadock","year":"2015"},{"key":"10.1016\/j.jpsychires.2019.10.004_bib41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/bcpt.12604","article-title":"Agmatine reverses sub-chronic stress induced nod-like receptor protein 3 (NLRP3) activation and cytokine response in rats","volume":"119","author":"Sahin","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib42","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.biopha.2016.11.073","article-title":"The role of NMDA receptor and nitric oxide\/cyclic guanosine monophosphate pathway in the antidepressant-like effect of dextromethorphan in mice forced swimming test and tail suspension test","volume":"85","author":"Sakhaee","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib43","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1196\/annals.1304.004","article-title":"Agmatine: at the crossroads of the arginine pathways","volume":"1009","author":"Satriano","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0165-0327(03)00135-6","article-title":"Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression","volume":"80","author":"Selley","year":"2004","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1601-5215.2012.00675.x","article-title":"The clinical antidepressant effect of exogenous agmatine is not reversed by parachlorophenylalanine: a pilot study","volume":"25","author":"Shopsin","year":"2013","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib46","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.biopha.2017.05.085","article-title":"Agmatine for combined treatment of epilepsy, depression and cognitive impairment in chronic epileptic animals","volume":"92","author":"Singh","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2013.10.041","article-title":"Agmatine attenuates chronic unpredictable mild stress induced behavioral alteration in mice","volume":"720","author":"Taksande","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib48","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pbb.2015.02.013","article-title":"Agmatine attenuates lipopolysaccharide induced anorexia and sickness behavior in rats","volume":"132","author":"Taksande","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.lfs.2017.08.032","article-title":"Agmatine attenuates intestinal ischemia and reperfusion injury by reducing oxidative stress and inflammatory reaction in rats","volume":"189","author":"Turan","year":"2017","journal-title":"Life Sci."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib50","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/14728222.2019.1581764","article-title":"Agmatine as a potential therapeutic intervention in bipolar depression: the preclinical landscape","volume":"23","author":"Watts","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jpsychires.2019.10.004_bib51","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0301-0082(00)00056-3","article-title":"Arginine metabolism and the synthesis of nitric oxide in the nervous system","volume":"64","author":"Wiesinger","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib52","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/13651501.2019.1569237","article-title":"Evaluation of plasma agmatine level and its metabolic pathway in patients with bipolar disorder during manic episode and remission period","volume":"23","author":"Yilmaz","year":"2019","journal-title":"Int. J. Psychiatry Clin. Pract."},{"issue":"1","key":"10.1016\/j.jpsychires.2019.10.004_bib53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ab.2003.11.006","article-title":"Simultaneous determination of arginine and seven metabolites in plasma by reversed-phase liquid chromatography with a time-controlled ortho-phthaldialdehyde precolumn derivatization","volume":"326","author":"Zhang","year":"2004","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jpsychires.2019.10.004_bib54","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00001756-200203250-00005","article-title":"Agmatine produces antidepressant-like effects in two models of depression in mice","volume":"13","author":"Zomkowski","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.jpsychires.2019.10.004_bib55","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.pnpbp.2006.05.016","article-title":"Putrescine produces antidepressant-like effects in the forced swimming test and in the tail suspension test in mice","volume":"30","author":"Zomkowski","year":"2006","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395619309008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395619309008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:12:33Z","timestamp":1758366753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395619309008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":55,"alternative-id":["S0022395619309008"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2019.10.004","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered plasma levels of arginine metabolites in depression","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2019.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}